Clinical Trial Update: Efficacy and Safety of Adalimumab 80 mg Every Other Week With Methotrexate [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the efficacy and safety of adalimumab 80 mg every other week in combination with methotrexate for rheumatoid arthritis.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Humira (adalimumab)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Keio University | Conditions: Rheumatoid Arthritis | Phase 4 | Status: UNKNOWN